Treosulfan Unknown Status Phase 2 Trials for Ocular Melanoma Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00168870Study of Metastatic Ocular Melanoma